composition; pharmaceutical composition; combination therapy; medical apparatus; method for administering at least one glycylcycline and at least one heparin; method for the administration of glycylcycline and heparin; method of treating intraabdominal infections with complications (ciai) and cutaneous infections and complications of the cutaneous structure (csssi) caused by gram negative and gram positive pathogens, anaerobic and methicillin-resistant strains and those resistant to staphylococcus aureus ( mssa and mrsa); method of treating intraabdominal infections with complications (ciai) and infections of the cutaneous and complicating skin structure (csssi) caused by gram negative and gram positive pathogens, anaerobic and methicillin-resistant strains of staphylococcus aureus ( mssa and mrsa) in a patient in need; antibiotic administration method; article of manufacture; kit; use of a glycylcillin of formula I or a pharmaceutically acceptable salt thereof; use of a heparin or pha

摘要

The present disclosure relates to tigecycline and heparin combination therapies and methods of administration of tigecycline and heparin.